Social Media Influencers Driving Unofficial Market for Unapproved Slimming Medication

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to contact these profiles directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to users injecting products of uncertain source.

Some experts stated the popularity for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, advertising, and customer regulations, risking fines, legal action or imprisonment.

Service Response and Content Elimination

According to TikTok, the platform has taken down violative content and banned associated hashtags and query recommendations. The company stated it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at home.

Within moments of joining one community, a vendor shared contact information, where most transactions take place. The vendor sent an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.

Item Details and Costs

Within these groups, posts show black plastic parcels with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how long a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they can’t verify. Although the science behind retatrutide is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already seen individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose users to possibly significant health risks”.